Search by Drug Name
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for RAPAMUNE
- Sirolimus for Improving Social Abilities in People With PTEN Germline Mutations
- Siplizumab for Sickle Cell Disease Transplant
- Advancing Transplantation Outcomes in Children
- Immunotherapy in Combination With Prednisone and Sirolimus for Kidney Transplant Recipients With Unresectable or Metastatic Skin Cancer
- Impacts of Mechanistic Target of Rapamycin (mTOR) Inhibition on Aged Human Muscle (Rapamune)
- TMLI and Alemtuzumab for Treatment of Sickle Cell Disease
- Different Doses of Sirolimus for the Maintenance Treatment of Kaposiform Hemangioendothelioma
- Effect of Rapamycin to Improve Cardiac Function in Frail Older Adults
- Assessing the Efficacy of Sirolimus in Patients With COVID-19 Pneumonia for Prevention of Post-COVID Fibrosis
- Sirolimus vs Corticosteroids in Treatment of Thyroid Eye Disease
- Phase III Trial of Sirolimus in IBM
- Efficacy and Safety of Different Concentrations of Sirolimus in the Treatment of Kaposiform Hemangioendothelioma.
- Participatory Evaluation (of) Aging (With) Rapamycin (for) Longevity Study
- Effects of mTOR Inhibition With Sirolimus (RAPA) in Patients With COVID-19 to Moderate the Progression of ARDS
- Haplo Peripheral Blood Sct In GVHD Prevention
- Efficacy and Safety of Sirolimus in COVID-19 Infection
- Standard Therapy Using Tacrolimus, Mycophenolate Mofetil and Prednisone For Chronic Lung Transplant Rejection (BOS)
- Sirolimus in COVID-19 Phase 1
- Sirolimus and Durvalumab for the Treatment of Stage I-IIIA Non-small Cell Lung Cancer
- Itacitinib, Tacrolimus, and Sirolimus for the Prevention of GVHD in Patients With Acute Leukemia, Myelodysplastic Syndrome, or Myelofibrosis Undergoing Reduced Intensity Conditioning Donor Stem Cell Transplantation
- Cemiplimab in AlloSCT/SOT Recipients With CSCC
- Cognition, Age, and RaPamycin Effectiveness - DownregulatIon of thE mTor Pathway
- Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergoing a Donor Stem Cell Transplant
- Enhancing Self Regulation Among Smokers
- Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms
- Sirolimus for Cowden Syndrome With Colon Polyposis
- Total Body Irradiation and Astatine-211-Labeled BC8-B10 Monoclonal Antibody for the Treatment of Nonmalignant Diseases
- NPC-12G Gel 0.2% Sirolimus PK Bridging Study
- Graft Versus Host Disease-Reduction Strategies for Donor Blood Stem Cell Transplant Patients With Acute Leukemia
- Sirolimus in Previously Treated Idiopathic Multicentric Castleman Disease
- Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial
- 211At-BC8-B10 Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory High-Risk Acute Leukemia or Myelodysplastic Syndrome
- Sirolimus vs Mycophenolate With Tacrolimus in Simultaneous Pancreas and Kidney Transplantation
- Human Lysozyme Goat Milk in Treating Patients With Blood Cancer Undergoing Donor Stem Cell Transplant
- Sirolimus-based Immunosuppression Treatment Regimen for Liver Transplantation
- Comparison of the Efficacy and Safety of Sirolimus Versus Everolimus Versus Mycophenolate in Kidney Transplantation
- Auranofin and Sirolimus in Treating Participants With Ovarian Cancer
- Topical Sirolimus Ointment for Cutaneous Angiofibromas in Subjects With Tuberous Sclerosis Complex
- Rapamycin Treatment for ALS
- Comparison of Triple GVHD Prophylaxis Regimens for Nonmyeloablative or Reduced Intensity Conditioning Unrelated Mobilized Blood Cell Transplantation
- Ixazomib in the Prophylaxis of Chronic Graft-versus-host Disease.
- Epacadostat (INCB24360) in Combination With Sirolimus in Advanced Malignancy
- Chemotherapy, Total Body Irradiation, and Post-Transplant Cyclophosphamide in Reducing Rates of Graft Versus Host Disease in Patients With Hematologic Malignancies Undergoing Donor Stem Cell Transplant
- Immunomodulatory Effects of Rapamycin on Pregnancy Rate of Patient With Recurrent Implantation Failure
- 211^At-BC8-B10 Before Donor Stem Cell Transplant in Treating Patients With High-Risk Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, Myelodysplastic Syndrome, or Mixed-Phenotype Acute Leukemia
- Sirolimus and Familial Adenomatous Polyposis (FAP)
- Nonmyeloablative Haploidentical Peripheral Blood Mobilized Hematopoietic Precursor Cell Transplantation for Sickle Cell Disease
- Trial of Sirolimus for Cognitive Impairment in Sturge-Weber Syndrome
- Calcineurin Inhibitor-Free GVHD Prevention Regimen After Related Haplo PBSCT
- Impact of Sirolimus and Maraviroc on CCR5 Expression and the HIV-1 Reservoir in HIV-infected Kidney Transplant Recipients
- Sirolimus (Rapamune ) for Relapse Prevention in People With Severe Aplastic Anemia Responsive to Immunosuppressive Therapy
- Ruxolitinib Phosphate and Chemotherapy Given Before and After Reduced Intensity Donor Stem Cell Transplant in Treating Patients With Myelofibrosis
- A Phase I/II GVHD Prevention Trial Combining Pacritinib With Sirolimus-Based Immune Suppression
- Abatacept for GVHD Prophylaxis After Hematopoietic Stem Cell Transplantation for Pediatric Sickle Cell Disease
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
- Bone Marrow Transplantation vs Standard of Care in Patients With Severe Sickle Cell Disease (BMT CTN 1503)
- Early Allogeneic Hematopoietic Cell Transplantation in Treating Patients With Relapsed or Refractory High-Grade Myeloid Neoplasms
- A Study of Rapamycin Combined With Intravesical BCG in Patients With Non-muscle Invasive Bladder Cancer
- Sirolimus and Mycophenolate Mofetil in Preventing GVHD in Patients With Hematologic Malignancies Undergoing HSCT
- Sirolimus Associated With Tacrolimus at Low Doses in Elderly Kidney Transplant Patients
- Nonmyeloablative Conditioning for Mismatched Hematopoietic Stem Cell Transplantation for Severe Sickle Cell Disease
- Conversion to Sirolimus: Effects in Cytomegalovirus Infection Recurrence
- High Dose Peripheral Blood Stem Cell Transplantation With Post Transplant Cyclophosphamide for Patients With Chronic Granulomatous Disease
- Prospective Pilot Trial to Assess a Multimodal Molecular Targeted Therapy in Children, Adolescent and Young Adults With Relapsed or Refractory High-grade Pineoblastoma
- Panobinostat (LBH589): Acute Graft Versus Host Disease (aGVHD) Prevention
- PLX3397 Plus Sirolimus in Unresectable Sarcoma and Malignant Peripheral Nerve Sheath Tumors
- Sirolimus in Combination With Metronomic Chemotherapy in Children With Recurrent and/or Refractory Solid and CNS Tumors
- Sirolimus, Docetaxel, and Carboplatin in Treating Patients With Metastatic Castration-Resistant Prostate Cancer
- Ruxolitinib Phosphate, Tacrolimus and Sirolimus in Preventing Acute Graft-versus-Host Disease During Reduced Intensity Donor Hematopoietic Cell Transplant in Patients With Myelofibrosis
- Sirolimus for the Treatment of Hyperinsulinism
- suPERficial Slow-flow Vascular malFORMations Treated With sirolimUS
- Minimal Islet Transplant at Diabetes Onset
- Examining the Impact of Sirolimus on Ketamine's Antidepressant Effects
- Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis
- Fucosylated T Cells for Graft Versus Host Disease (GVHD) Prevention
- Systemic Rapamycin (Sirolimus) to Prevent In-Stent Restenosis Following Pulmonary Artery Stent Placement
- Bioavailability Study of Sirolimus Tablets 2 mg Under Fed Condition
- Bioavailability Study of Sirolimus Tablets 2 mg Under Fasting Condition
- Treatment of Port Wine Stains Using Pulsed Dye Laser, Erbium Yag Laser and Topical Sirolimus
- Sirolimus Prophylaxis for aGVHD in TME SCID
- Everolimus for Children With Recurrent or Progressive Ependymoma
- Auranofin and Sirolimus in Treating Patients With Advanced Solid Tumors or Recurrent Non-Small Cell Lung Cancer
- Calcineurin Inhibitor Based Immunosuppression Withdrawal
- A Study to Compare Vincristine to Sirolimus for Treatment of High Risk Vascular Tumors
- Safety of Simvastatin in LAM and TSC
- Pulsed Oral Sirolimus in Autosomal Dominant Polycystic Kidney Disease
- Prospective Evaluation of the Efficacy of Sirolimus (Rapamune®) in the Treatment of Severe Arteriovenous Malformations
- Comparing Everolimus and Sirolimus in Renal Transplant Recipients
- Study Comparing in Livertransplantation Recipients With Tacrolimus Alone Versus Tacrolimus&Sirolimus
- In Vivo Treg Expansion and Graft-Versus-Host Disease Prophylaxis
- Sirolimus, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients At High Risk for Cholangiocarcinoma Recurrence After Liver Transplant or Surgery
- Clofarabine and Melphalan Before Donor Stem Cell Transplant in Treating Patients With Myelodysplasia, Acute Leukemia in Remission, or Chronic Myelomonocytic Leukemia
- Sirolimus and Azacitidine in Treating Patients With High Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia That is Recurrent or Not Eligible for Intensive Chemotherapy
- Tuberous Sclerosis Complex: Facial Angiofibroma Skin Cream
- Sirolimus, Idarubicin, and Cytarabine in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia
- A Study to Evaluate the Effect of Multiple Doses of Isavuconazole on the Pharmacokinetics of a Single Dose of Sirolimus in Healthy Subjects
- Sirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery
- Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma
- Tacrolimus, Sirolimus and Ustekinumab vs. Tacrolimus and Sirolimus for the Prevention of Acute Graft-Versus-Host Disease
- Hydroxychloroquine, Cyclophosphamide, Dexamethasone, and Sirolimus in Treating Patients With Relapsed or Refractory Multiple Myeloma
- Study to Evaluate the Safety and Efficacy of Extended Release Tacrolimus (Advagraf®) + Sirolimus (Rapamune®), Versus Extended Release Tacrolimus (Advagraf®) + Mycophenolate Mofetil in Kidney Transplant Patients
- Sirolimus for Massive Polycystic Liver
- Using mTOR Inhibitors in the Prevention of BK Nephropathy
- The Vienna RAP Pilot Study
- Rapamune Improves Outcomes of Severe H1N1 Pneumonia
- Open Label Comparative Study Of De Novo Renal Allograft Recipients Receiving CSA + MMF + Corticosteroids Versus CSA + Rapamune + Corticosteroids
- Study to Evaluate Safety and Immunologic Biomarker of Rapamune in Patients With Stable Renal Transplant Recipient
- Sirolimus and Vismodegib in Treating Patients With Solid Tumors or Pancreatic Cancer That is Metastatic or Cannot Be Removed By Surgery
- Sirolimus and Vaccine Therapy in Treating Patients With Stage II-IV Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity Cancer
- High Dose Busulfan and Bortezomib in Treating Patients With High Risk Multiple Myeloma Undergoing Stem Cell Transplant
- Vaccine Therapy With or Without Sirolimus in Treating Patients With NY-ESO-1 Expressing Solid Tumors
- Ph I/II Study of Allogeneic SCT for Clinically Aggressive Sickle Cell Disease (SCD)
- Kidney Allograft Dysfunction Without Reversible Causes
- Treatment of Children With Kidney Transplants by Injection of CD4+CD25+FoxP3+ T Cells to Prevent Organ Rejection
- Minitransplants With HLA-matched Donors : Comparison Between 2 GVHD Prophylaxis Regimens
- Sirolimus and Gold Sodium Thiomalate in Treating Patients With Advanced Squamous Non-Small Cell Lung Cancer
- Efficacy of Sirolimus In Liver Transplantation for Hepatocellular Carcinoma (HCC)
- A Study Looking at Kidney Function in Kidney Transplant Recipients Who Are Taking Anti-rejection Medication Including Tacrolimus and With or Without Sirolimus.
- Aflac ST0901 CHOANOME - Sirolimus in Solid Tumors
- Research Study of ATG and Rituximab in Renal Transplantation
- Immunosuppressive Medications for Participants in ITN005CT (NCT00014911)
- Sirolimus or Vorinostat and Hydroxychloroquine in Advanced Cancer
- Sirolimus, Cyclosporine, and Mycophenolate Mofetil in Preventing Graft-versus-Host Disease in Treating Patients With Blood Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant
- Study To Evaluate Pharmacokinetics Of Sirolimus In Stable Renal Transplant Recipients
- Graft-Versus-Host Disease Prophylaxis in Treating Patients With Hematologic Malignancies Undergoing Unrelated Donor Peripheral Blood Stem Cell Transplant
- Sirolimus In Autosomal Dominant Polycystic Kidney Disease And Severe Renal Insufficiency
- Sirolimus & Mycophenolate Mofetil as GvHD Prophylaxis in Myeloablative, Matched Related Donor HCT
- Bortezomib, Total Marrow Irradiation, Fludarabine Phosphate, and Melphalan in Treating Patients Undergoing Donor Peripheral Blood Stem Cell Transplant For High-Risk Stage I or II Multiple Myeloma
- Study of Vinblastine and Sirolimus in Children With Recurrent/Refractory Solid Tumours Including CNS Tumours
- Study of Sirolimus Versus Mycophenolate Liver Transplant Recipients With Recurrent Hepatitis C Virus (HCV)
- Campath, Calcineurin Inhibitor Reduction and Chronic Allograft Nephropathy
- Chronic Graft-versus-Host Disease Treatment (BMT CTN 0801)
- Lapatinib With Sirolimus or Metformin
- Sirolimus or Everolimus or Temsirolimus and Vorinostat in Advanced Cancer
- Pre Transplant Rapamycin Treatment in Islet Transplantation Alone
- Docetaxel and Sirolimus in Patients With Advanced Malignancies
- Rapamycin and Regulatory T Cells in Kidney Transplantation
- Bortezomib Before Donor Stem Cell Transplant in Treating Patients With Multiple Myeloma
- Trial of Continuous Once Daily Oral Treatment Using BIBW 2992 (Afatinib) Plus Sirolimus (Rapamune®) in Patients With Non-small Cell Lung Cancer Harbouring an EGFR Mutation and/or Disease Progression Following Prior Erlotinib or Gefitinib
- Randomized Trial Comparing Sirolimus and Tacrolimus Versus Cyclosporine and Methotrexate as Graft-versus-host Disease (GVHD) Prophylaxis After Allogeneic Stem Cell Transplantation
- Haploidentical PBMC Transplant for Severe Congenital Anemias
- Safety and Efficacy Study of Sirolimus in Complicated Vascular Anomalies
- Sirolimus to Treat Cowden Syndrome and Other PTEN Hamartomatous Tumor Syndromes
- Sirolimus and Cetuximab in Advanced Malignancies
- Polycystic Liver Disease in Kidney Transplant
- Topical Rapamycin for Fibrofolliculomas
- Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer
- Sirolimus and Pemetrexed to Treat Non-Small Cell Lung Cancer
- Effectiveness of Conversion to Sirolimus Versus Calcineurin Inhibitor (CNI) Reduction in Renal Transplant Patients With Prostate Cancer
- Kidney Biopsy Controlled Trial of Calcineurin Inhibitor Withdrawal
- Study Evaluating A Planned Transition From Tacrolimus To Sirolimus In Kidney Transplant Recipients
- Randomized Conversion of Calcineurin-Inhibitors in Renal Allograft Recipients
- Oral Sirolimus for In-Stent Restenosis
- Calcineurin Free Immunosuppression in Renal Transplant Recipients
- Study to Compare the Safety and Efficacy of Sirolimus (Rapamune) to Tacrolimus (Advagraf) Associated to Mycophenolate Mofetil (CellCept) Between 12 and 36 Months After Kidney Transplantation
- Pilot Study of mTOR Inhibitor Therapy in Peutz-Jeghers Syndrome
- Combination Chemotherapy With or Without Donor Stem Cell Transplant in Treating Patients With Acute Lymphoblastic Leukemia
- Safety and Effectiveness of Low Molecular Weight Sulfated Dextran in Islet Transplantation After Kidney Transplant
- Prospective Study of Rapamycin for the Treatment of SLE
- Safety of Immunosuppression Minimization in Children and Adolescents After Kidney Transplantation
- Study Evaluating Conversion From Tacrolimus to Sirolimus in Stable Kidney Transplant Recipients Receiving Myfortic
- Sirolimus to Treat Diabetic Macular Edema
- Study of Rapamycin Plus Ketoconazole in Advanced Cancers
- Rapamycin in Advanced Cancers
- Study Evaluating The Use Of Sirolimus In Recipients Of Kidney Allografts From Expanded Criteria Donors (ECD)
- A Study To Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids
- Raptiva and Sirolimus in Islet Transplantation for Type 1 Diabetes
- Rapamycin Plus Bevacizumab in Advanced Cancers
- A Phase II Study of the mTOR Inhibitor Sirolimus in Neurofibromatosis Type 1 Related Plexiform Neurofibromas
- Comparing Three Different Combination Chemotherapy Regimens in Treating Patients With Relapsed or Refractory Acute Myeloid Leukemia
- Rapamycin for Prevention of Chronic Graft-Versus-Host Disease
- Pharmacokinetic Drug Interaction Between Ezetimibe and Sirolimus After Single Dose Administration in Healthy Subjects
- Sirolimus, Tacrolimus and Short Course Methotrexate for Prevention of Acute GVHD in Recipients of Mismatched Unrelated Donor Allogeneic Stem Cell Transplantation
- CNI-free de Novo Protocol in Patients Undergoing Liver Transplantation With Renal Impairment
- Interaction Study of Rapamycin and Sunitinib in Patients With Advanced Cancers
- Yttrium Y 90 Ibritumomab Tiuxetan, Rituximab, Indium In-111 Ibritumomab Tiuxetan, Fludarabine, Melphalan, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin Lymphoma
- Belatacept Post Depletional Repopulation to Facilitate Tolerance
- Pediatric Kidney Transplant Study of Sirolimus, Mycophenolate Mofetil, and Corticosteroids vs Calcineurin Inhibitor Based Immunosuppression
- Rapamycin Versus Mycophenolate Mofetil in Kidney-Pancreas Recipients
- Proleukin and Rapamune in Type 1 Diabetes
- Thymoglobulin, Sirolimus and Mycophenolate Mofetil for Prevention of Acute Graft-Versus-Host Disease (GVHD)
- Sirolimus in Treating Patients With Advanced Pancreatic Cancer
- Non-Myeloablative Bone Marrow Transplant for Patients With Sickle Cell Anemia and Other Blood Disorders
- Study Investigating Rapamune For Post-Marketing Surveillance
- Study Evaluating Rapamune® Maintenance Regimen
- Study Comparing Sirolimus/Prograf vs Sirolimus/CsA in High-Risk Renal Transplant Recipients
- B-Lymphocyte Immunotherapy in Islet Transplantation
- Drug Interaction Study of Sorafenib and Rapamycin in Advanced Malignancies
- Islet Allotransplantation With Steroid Free Immunosuppression
- A Phase II Study of Rapamycin and Trastuzumab for Patients With HER-2 Receptor Positive Metastatic Breast Cancer
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)
- Study of Combination of Sirolimus and Sutent in Patients With Advanced Solid Tumors Non-Curable With Standard Therapy
- Sirolimus for Autoimmune Disease of Blood Cells
- Sirolimus as Treatment of Steroid-Refractory or Steroid-Dependent Chronic Graft-Versus-Host Disease
- Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission
- Rapamycin With Grapefruit Juice for Advanced Malignancies
- Study to Evaluate Safety and Efficacy of Early Calcineurin Inhibitor Withdrawal in Primary Renal Allografts
- Sirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors
- Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation Followed by Donor Bone Marrow Transplant and Cyclophosphamide, Mycophenolate Mofetil, Tacrolimus, and Sirolimus in Treating Patients With Primary Immunodeficiency Disorders or Nonca
- Immunosuppression in Patients Undergoing Liver Transplantation for Hepatocellular Carcinoma
- Erlotinib and Sirolimus for the Treatment of Metastatic Renal Cell Carcinoma
- Pilot Study for HLA Identical Living Donor Renal Transplant Recipients
- Sirolimus (Rapamune®) for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- Belatacept to Prevent Organ Rejection in Kidney Transplant Patients
- A Study of the mTOR Inhibitor Rapamycin (Rapamune, Sirolimus) in Combination With Abraxane in Advanced Solid Cancers
- De Novo Sirolimus-based Immunosuppression After Liver Transplantation for Hepatocellular Carcinoma
- Sirolimus and Cyclosporine for Treatment-Resistant Aplastic Anemia
- Pilot Study of Rapamycin as Treatment for Autosomal Dominant Polycystic Kidney Disease (ADPKD)
- The Comparison of Tacrolimus and Sirolimus Immunosuppression Based Drug Regimens in Kidney Transplant Recipients
- Study Comparing Conversion From Calcineurin Inhibitors to Rapamune Versus Standard Therapy in Established Renal Allograft Recipients
- Study Evaluating Cyclosporine Dose Reduction and Cyclosporine Elimination in Chinese Kidney Transplants
- Use of Sirolimus vs. Tacrolimus For African-American Renal Transplant Recipients
- Study Comparing Cyclosporin Dose Reduction With Cyclosporin Elimination in Kidney Transplant Recipients Taking Sirolimus
- Study Evaluating Rapamune in Patients After Kidney Transplantation
- Study Evaluating Sirolimus in Kidney Transplant Recipients in India
- Study Comparing Cyclosporine Dose Reduction vs. Cyclosporine Elimination in Kidney Transplant Recipients Taking Sirolimus
- Study Evaluating Rapamune in Transplant Recipients in the Nordic Countries
- Efficacy of Sirolimus-Based, Steroid Avoidance Immunosuppression African Americans
- Comparison of Sirolimus to Tacrolimus for Long Term Therapy in Kidney Transplant With no Steroids
- TUMORAPA 1: Efficacy of Rapamycin in Secondary Prevention of Skin Cancers in Kidney Transplant Recipients
- Kidney Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Kidney Transplant Recipients
- Heart Spare the Nephron (STN) Study - A Study of CellCept (Mycophenolate Mofetil) and Rapamune (Sirolimus) in Heart Transplant Recipients
- Gefitinib and Sirolimus in Treating Patients With Recurrent or Refractory Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Study Evaluating of Calcineurin Inhibitor and Sirolimus (Rapamune) Treatment in Liver Transplant Recipients
- Sirolimus as Secondary Therapy in Chronic Graft-Versus-Host Disease Not Responding To Prior Treatment
- Sirolimus in Treating Young Patients With Relapsed or Refractory Acute Leukemia or Non-Hodgkin's Lymphoma
- Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias
- Improving Immunosuppressive Treatment for Patients With Severe Aplastic Anemia
- Study Evaluating Sirolimus in End Stage Renal Disease in High Risk Kidney Transplant Recipients
- Stem Cell Transplantation in Patients With High-Risk and Recurrent Pediatric Sarcomas
- Sirolimus for Focal Segmental Glomerulosclerosis
- Study Evaluating Sirolimus (Rapamune™) in Solid Organ Transplant Recipients
- Pediatric Kidney Transplant Without Calcineurin Inhibitors
Clinical trials list
click for details